Beam Therapeutics (BEAM) P/E (2020 - 2026)
Beam Therapeutics (BEAM) P/E from Feb 6, 2020 to Jul 21, 2026. The TTM Beam Therapeutics (BEAM) P/E is -41.75. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Beam Therapeutics (BEAM)
| Year | P/E | Change |
|---|---|---|
| 2026 | -41.75 | +22.44% |
| 2025 | -34.10 | +526.39% |
| 2024 | -5.44 | -17.88% |
| 2023 | -6.63 | -23.44% |
| 2022 | -8.66 | -36.88% |
| 2021 | -13.72 | -38.50% |
| 2020 | -22.30 | N/A |
Comparison Beam Therapeutics (BEAM) P/E with competitors
Beam Therapeutics (BEAM) P/E is -41.75.